1. Home
  2. BEN vs ICLR Comparison

BEN vs ICLR Comparison

Compare BEN & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Franklin Resources Inc.

BEN

Franklin Resources Inc.

HOLD

Current Price

$23.40

Market Cap

12.1B

Sector

Finance

ML Signal

HOLD

Logo ICON plc

ICLR

ICON plc

HOLD

Current Price

$185.83

Market Cap

14.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BEN
ICLR
Founded
1947
1990
Country
United States
Ireland
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Commercial Physical & Biological Resarch
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.1B
14.3B
IPO Year
N/A
1998

Fundamental Metrics

Financial Performance
Metric
BEN
ICLR
Price
$23.40
$185.83
Analyst Decision
Hold
Buy
Analyst Count
11
14
Target Price
$23.05
$201.23
AVG Volume (30 Days)
4.3M
1.0M
Earning Date
11-07-2025
10-22-2025
Dividend Yield
5.47%
N/A
EPS Growth
7.28
N/A
EPS
0.91
7.47
Revenue
$8,770,700,000.00
$8,102,602,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$5.60
$0.76
P/E Ratio
$25.71
$24.87
Revenue Growth
3.45
N/A
52 Week Low
$16.25
$125.10
52 Week High
$26.08
$228.29

Technical Indicators

Market Signals
Indicator
BEN
ICLR
Relative Strength Index (RSI) 60.98 62.18
Support Level $22.34 $174.13
Resistance Level $23.54 $191.15
Average True Range (ATR) 0.46 8.46
MACD 0.19 2.87
Stochastic Oscillator 94.44 85.77

Price Performance

Historical Comparison
BEN
ICLR

About BEN Franklin Resources Inc.

Franklin Resources provides investment services for individual and institutional investors. At the end of July 2025, Franklin had $1.617 trillion in managed assets, composed primarily of equity (41%), fixed-income (27%), multi-asset/balanced (11%) funds, alternatives (16%) and money market funds (5%). Distribution tends to be weighted between retail investors (56% of AUM) and institutional accounts (41%), with high-net-worth clients accounting for the remainder. Franklin is one of the more global of the US-based asset managers we cover, with 31% of its assets under management invested in global/international strategies and just as much sourced from clients domiciled outside the United States.

About ICLR ICON plc

Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.

Share on Social Networks: